CSS
KRON

Cubist Systematic Strategies’s Kronos Bio KRON Stock Holding History

Cubist Systematic Strategies’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,174
Closed -$25K – 3257
2024
Q2 		$25K Sell
20,174
-10,117
-33% -$10.3K ﹤0.01% 2761
2024
Q1 		$39.4K Buy
+30,291
New +$34.5K ﹤0.01% 3410
2023
Q3 		– Sell
-13,578
Closed -$23.4K – 3661
2023
Q2 		$23.4K Buy
13,578
+1,887
+16% +$3K ﹤0.01% 3168
2023
Q1 		$17.1K Buy
11,691
+2,887
+33% +$5.54K ﹤0.01% 3681
2022
Q4 		$14.3K Sell
8,804
-22,101
-72% -$50.9K ﹤0.01% 4023
2022
Q3 		$104K Sell
30,905
-2,042
-6% -$9.22K ﹤0.01% 4003
2022
Q2 		$120K Buy
+32,947
New +$149K ﹤0.01% 3901
2022
Q1 		– Sell
-32,230
Closed -$438K – 3668
2021
Q4 		$438K Buy
+32,230
New +$504K ﹤0.01% 2539
2021
Q3 		– Sell
-7,905
Closed -$189K – 3064
2021
Q2 		$189K Buy
+7,905
New +$200K ﹤0.01% 2586

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's KRON Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Kronos Bio (KRON) in Q3 2024, closing a stake of 20,174 shares — an estimated $25K sold.

Cubist Systematic Strategies first reported a position in KRON in Q2 2021 and held it in 9 quarters. The position peaked at $438K in Q4 2021. 53 funds tracked by Wall St. Rank hold KRON as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Kronos Bio position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 20,174 Kronos Bio shares in Q3 2024, an estimated $25K.
  • Cubist Systematic Strategies first reported a position in Kronos Bio in Q2 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's Kronos Bio position peaked at $438K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.